against the vaccine antigens39,40.
influenza vaccinations) can dampen the immune respons
repeated immunisation (for example during repeated annua
overcome this issue, AdV vector immunity developed throug
the use of non-human adenovirus vectors could potentiall
the vaccine vector and clearing the vector-infected cells. Whil
adenovirus can hamper vaccine effectiveness by neutralisin
disease39â€“41.However,pre-existingoracquiredimmunityagains
protein, providing robust protection against the targete
bothcell-mediatedandhumoralimmunityagainsttheexpresse
transgeneexpressionofrHAinthehostcells.AdVvectorsinduc
primarily as a replication-defective vector, for gene delivery an
Several groups have explored the use of adenovirus (AdV